NCT00052572 2013-06-24Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative DisordersNational Cancer Institute (NCI)Phase 2 Completed35 enrolled
NCT00030108 2012-03-15Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to TherapyNational Institutes of Health Clinical Center (CC)Phase 1 Completed30 enrolled